Literature DB >> 9611675

Serotonin transporter gene and risk for bipolar affective disorder: an association study in Spanish population.

B Gutiérrez1, M J Arranz, D A Collier, V Vallès, R Guillamat, J Bertranpetit, R M Murray, L Fãnás.   

Abstract

BACKGROUND: The serotonin transporter (5-HTT) is an important candidate gene for the genetic transmission of manic depressive illness. Many studies of patients with affective disorders have found abnormalities in serotonin metabolism and dysregulation of the transporter itself. In the present study, we hypothesize that genetic variation in the 5-HTT gene (17q11.1-17q12) may have an effect in the etiology of manic depression.
METHODS: To test this hypothesis, we analyzed allele, genotype, and haplotype frequencies of two polymorphisms recently described in the 5-HTT gene (a variable number of tandem repeats in intron 2 and a deletion/insertion polymorphism in the transcriptional control region) in a sample of 88 patients with manic-depressive illness and 113 controls. Cases and controls were matched for ethnic and geographic origin.
RESULTS: No associations were found between any of these polymorphisms, tested individually or as haplotypes, and manic depression. Moreover, the genetic analysis by sex, presence/absence of psychiatric family history, and age of onset did not reveal significant differences in allele or genotype distributions.
CONCLUSIONS: Our results suggest that the genetic variability of the 5-HTT gene is not a major risk factor for manic depression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9611675     DOI: 10.1016/s0006-3223(97)00540-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

Review 1.  Recent progress in the search for genes for bipolar disorder.

Authors:  J R Kelsoe
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

3.  Allelic association analysis of the functional insertion/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder.

Authors:  Ivanor Meira-Lima; Leandro Michelon; Quirino Cordeiro; Hyong Jin Cho; Homero Vallada
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 4.  Pharmacogenetics of bipolar disorder.

Authors:  Hader A Mansour; Martin Alda; Vishwajit L Nimgaonkar
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 5.  Genetics of bipolar affective disorder.

Authors:  J I Nurnberger; T Foroud
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

6.  Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers.

Authors:  Maria J Arranz; Juliana Salazar; Valentin Bote; Alicia Artigas-Baleri; Alexandre Serra-LLovich; Emma Triviño; Jordi Roige; Carlos Lombardia; Martha Cancino; Marta Hernandez; Marc Cendros; Enric Duran-Tauleria; Natalia Maraver; Amaia Hervas
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

Review 7.  The genetics of early-onset bipolar disorder: A systematic review.

Authors:  Kevin P Kennedy; Kathryn R Cullen; Colin G DeYoung; Bonnie Klimes-Dougan
Journal:  J Affect Disord       Date:  2015-05-15       Impact factor: 4.839

8.  Genes in the serotonin pathway are associated with bipolar affective disorder in a Han Chinese population.

Authors:  Bo Xiang; Zhenxing Yang; Yin Lin; Lijie Guan; Xuan Li; Wei Deng; Zeyu Jiang; Guohui Lao; Qiang Wang; Xiaoyu Hao; Xiang Liu; Yingcheng Wang; Liansheng Zhao; Xiaohong Ma; Tao Li; Liping Cao; Xun Hu
Journal:  Neurosci Bull       Date:  2013-10-17       Impact factor: 5.203

9.  Meta-analysis of genetic association studies on bipolar disorder.

Authors:  Fayaz Seifuddin; Pamela Belmonte Mahon; Jennifer Judy; Mehdi Pirooznia; Dubravka Jancic; Jacob Taylor; Fernando S Goes; James B Potash; Peter P Zandi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-09       Impact factor: 3.568

10.  Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Authors:  R Rajkumar; R Mahesh
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.